Beta
38556

A new local anesthetic "levobupivacaine" for the "3-in-1" lumbar plexus block in children

Thesis

Last updated: 06 Feb 2023

Subjects

-

Tags

Anesthesiology

Advisors

Shaltout, Foudan F. , Dous, Layla H. , Gouda, Nivin M.

Authors

Ghaith, Azza Galal

Accessioned

2017-04-26 12:29:51

Available

2017-04-26 12:29:51

type

M.D. Thesis

Abstract

Regional anesthesia and peripheral nerve blocks are now used widely in children mostly in combination with general anesthesia they provide part of anesthetic requirement and significantly improve patient comfort in postoperative period. The need exists for a long acting local anesthetic that enjoys the benefits of bupivacaine but with lower potential for toxicity. Levobupivacaine (chirocaine) a new local anesthetic which is the S (-) isomer of bupivacaine is provided by Ben Venue laboratories the evidence from animal and human volunteers studies demonstrated that levobupivacaine is consistently less toxic than bupivacaine. The study aims to evaluate the value of “3-in-1” continuous lumbar plexus block in children in intra and postoperative pain management and intraoperative anesthetic consumption comparing a new local anesthetic levobup- ivacaine to ropivacaine for performance of the block. The continuous "3-in-1" lumbar plexus block is used to relief pain in knee, hip, surgeries, relief tourniquet pain and during transportation and x-ray of fracture femur in both adults and children. For this reason catheter should be advanced as proximal (near L3 and L4) as possible . This blocks femoral, obturator, and the lateral femoral cutaneous nerve of thigh.

Issued

1 Jan 2005

DOI

http://dx.doi.org/10.21473/iknito-space/32500

Details

Type

Thesis

Created At

28 Jan 2023